Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04. (Q51798935)
Jump to navigation
Jump to search
scientific article published in January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04. |
scientific article published in January 2010 |
Statements
Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04. (English)
1 reference
Mark G Carmichael
1 reference
Linda C Benavides
1 reference
Jarrod P Holmes
1 reference
Jeremy D Gates
1 reference
Elizabeth A Mittendorf
1 reference
Sathibalan Ponniah
1 reference
George E Peoples
1 reference
1 January 2010
1 reference
1 reference
116
1 reference
2
1 reference
292-301
1 reference
Identifiers
1 reference